| Literature DB >> 35464908 |
Jingyu Zhu1, Xue Tang1, Yining Sun1, Yan Li1, Yajie Wang1, Yusong Jiang2, Huanhuan Shao1, Bin Yong1, Honghao Li3, Xiang Tao1.
Abstract
Late blight is one of the main biological stresses limiting the potato yield; however, the biochemical mechanisms underlying the infection process of Phytophthora infestans remain unrevealed. In this study, the late blight-resistant potato cultivar Ziyun No.1 (R) and the susceptible cultivar Favorita (S) were inoculated with P. infestans. Untargeted metabolomics was used to study the changes of metabolites in the compatible and incompatible interactions of the two cultivars and the pathogen at 0, 48, and 96 h postinoculation (hpi). A total of 819 metabolites were identified, and the metabolic differences mainly emerged after 48 hpi. There were 198 and 115 differentially expressed metabolites (DEMs) in the compatible and incompatible interactions. These included 147 and 100 upregulated metabolites during the compatible and incompatible interactions, respectively. Among them, 73 metabolites were identified as the P. infestans-responsive DEMs. Furthermore, the comparisons between the two cultivars identified 57 resistance-related metabolites. Resistant potato cultivar had higher levels of salicylic acid and several upstream phenylpropanoid biosynthesis metabolites, triterpenoids, and hydroxycinnamic acids and their derivatives, such as sakuranetin, ferulic acid, ganoderic acid Mi, lucidenic acid D2, and caffeoylmalic acid. These metabolites play crucial roles in cell wall thickening and have antibacterial and antifungal activities. This study reports the time-course metabolomic responses of potatoes to P. infestans. The findings reveal the responses involved in the compatible and incompatible interactions of potatoes and P. infestans.Entities:
Keywords: Phytophthora infestans; compatible; incompatible; metabolomics; potato cultivars
Year: 2022 PMID: 35464908 PMCID: PMC9024415 DOI: 10.3389/fmicb.2022.857160
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Phenotypic changes of potato leaves at different time points of Phytophthora infestans infection. Virus-free seedlings of Favorita (A) and Ziyun No.1 (B) inoculated with P. infestans isolate SCPZ16-3-1 at 0 h before infection (hbi), 48 h postinoculation (hpi), and 96 hpi.
FIGURE 2Correlation analyses of the different samples collected from the compatible and incompatible interactions. (A) Sample correlation Partial Least Squares-Discriminant Analysis (PLS-DA) diagram. (B) Sample correlation heatmap. R1, R2, and R3 represent the samples collected at 0, 48, and 96 hpi, respectively, in incompatible interactions. S1, S2, and S3 denote the samples collected at 0, 48, and 96, respectively, in the compatible interactions. QC, quality control sample.
FIGURE 3Differentially expressed metabolites (DEMs) identified during the infection process. (A) DEMs identified during the compatible interactions. (B) DEMs identified during the incompatible interactions. (C) DEMs identified between the compatible and incompatible interactions. (D) Change trend of the DEMs in the compatible (the values before the slash) and the incompatible (the values after the slash) interactions.
FIGURE 4Expression levels of some annotated metabolites.
Late blight resistance-related (RR) metabolites identified in resistant potato cultivar.
| Metab ID | Metabolite | Class | S1 | S2 | S3 | R1 | R2 | R3 |
| metab_8880 | Beta1-tomatidine | Steroids and steroid derivatives | 1.813 | 2.147 | 1.275 | 3.120 | 2.675 | 2.734 |
| metab_10888 | Alpha-solamarine | Steroids and steroid derivatives | 1.152 | 1.015 | 1.031 | 3.200 | 1.954 | 2.049 |
| metab_11205 | Coroloside | Steroids and steroid derivatives | 0.932 | 0.887 | 1.113 | 1.778 | 2.298 | 2.379 |
| metab_13219 | 18-hydroxycortisol | Steroids and steroid derivatives | 0.073 | 0.152 | 0.490 | 2.055 | 2.286 | 2.229 |
| metab_14158 | Tetrahydroaldosterone-3-glucuronide | Steroids and steroid derivatives | 2.448 | 2.253 | 1.645 | 3.249 | 3.410 | 3.262 |
| metab_13870 | Yuccoside C | Steroids and steroid derivatives | 0.520 | 0.511 | 0.524 | 2.744 | 1.940 | 2.027 |
| metab_2817 | Coprocholic acid | Steroids and steroid derivatives | 1.925 | 1.444 | 1.636 | 2.789 | 2.348 | 2.515 |
| metab_6384 | Polypodoside C | Steroids and steroid derivatives | 0.449 | 0.545 | 0.635 | 2.032 | 1.464 | 1.733 |
| metab_10764 | Halobetasol propionate | Steroids and steroid derivatives | 0.780 | 1.358 | 1.506 | 2.387 | 2.357 | 2.289 |
| metab_1467 | Chinenoside VI | Steroids and steroid derivatives | 1.137 | 1.121 | 1.229 | 2.483 | 2.019 | 2.018 |
| metab_6929 | Ponasteroside A | Steroids and steroid derivatives | 2.196 | 2.391 | 1.844 | 3.687 | 3.394 | 3.459 |
| metab_3718 | Fistuloside B | Steroids and steroid derivatives | 0.733 | 0.706 | 1.246 | 2.459 | 2.145 | 2.141 |
| metab_6336 | Neogitogenin 3-[glucosyl-(1- > 2)-glucosyl-(1- > 4)-galactoside] | Steroids and steroid derivatives | 3.115 | 3.391 | 3.487 | 4.415 | 4.058 | 4.209 |
| metab_8968 | Alliosterol 1-(4′′-galactosylrhamnoside) 16-galactoside | Steroids and steroid derivatives | 2.620 | 2.480 | 0.887 | 3.692 | 3.109 | 3.182 |
| metab_6682 | 25-hydroxyvitamin D3-26,23-lactol | Steroids and steroid derivatives | 0.804 | 0.788 | 0.907 | 2.660 | 2.271 | 2.387 |
| metab_14064 | 12-hydroxy-13- | Saccharolipids | 1.347 | 1.529 | 1.487 | 2.276 | 2.799 | 2.582 |
| metab_10366 | Alkaloid RC | Rheadine alkaloids | 1.700 | 1.708 | 1.414 | 2.928 | 3.125 | 2.970 |
| metab_6468 | Zanthodioline | Quinolines and derivatives | 1.340 | 1.175 | 1.280 | 1.941 | 1.686 | 2.130 |
| metab_11087 | Riboflavine 2′,3′,4′,5′-tetrabutanoate | Pteridines and derivatives | 0.263 | 0.415 | 0.923 | 1.811 | 1.995 | 1.828 |
| metab_15462 | Monotropein | Prenol lipids | 0.861 | 1.877 | 0.777 | 2.563 | 2.518 | 2.364 |
| metab_11767 | Lucidenic acid D2 | Prenol lipids | 0.004 | 0.004 | 0.042 | 1.287 | 1.845 | 1.852 |
| metab_6925 | Schidigeragenin B | Prenol lipids | 1.077 | 1.061 | 1.168 | 2.413 | 1.854 | 2.058 |
| metab_14681 | Assamsaponin F | Prenol lipids | 2.469 | 2.593 | 2.236 | 4.019 | 3.704 | 3.725 |
| metab_8277 | (1R*,2R*,4R*,8S*)- | Prenol lipids | 2.903 | 2.981 | 2.662 | 3.503 | 3.706 | 3.454 |
| metab_11510 | Goshonoside F1 | Prenol lipids | 1.263 | 1.224 | 1.322 | 1.950 | 2.147 | 2.216 |
| metab_5461 | Ganoderic acid Mi | Prenol lipids | 0.416 | 0.653 | 0.898 | 2.392 | 1.921 | 2.491 |
| metab_3043 | 5- | Organooxygen compounds | 1.190 | 1.395 | 1.898 | 1.897 | 1.861 | 2.480 |
| metab_10398 | 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-pyridinium (HPP+) | Organooxygen compounds | 1.358 | 1.661 | 0.891 | 2.527 | 2.329 | 2.282 |
| metab_7239 | Galactose-beta-1,4-xylose | Organooxygen compounds | 1.450 | 1.560 | 1.311 | 2.192 | 2.161 | 2.134 |
| metab_1020 | 3,4,5-trihydroxy-6-(2-hydroxy-6-methoxyphenoxy)oxane-2-carboxylic acid | Organooxygen compounds | 0.886 | 1.215 | 0.766 | 2.401 | 1.959 | 2.107 |
| metab_15233 | Caffeic acid 4- | Organooxygen compounds | 1.948 | 2.152 | 1.778 | 3.388 | 2.793 | 2.826 |
| metab_10661 | 3,4,5-trihydroxy-6-{[3-(3-hydroxyphenyl)propanoyl]oxy}oxane-2-carboxylic acid | Organooxygen compounds | 1.496 | 1.884 | 2.446 | 3.278 | 2.807 | 3.221 |
| metab_3695 | 6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol | Organooxygen compounds | 1.063 | 1.080 | 0.716 | 2.327 | 2.586 | 2.019 |
| metab_10121 | Organic sulfuric acids and derivatives | 1.168 | 1.446 | 0.704 | 1.887 | 2.016 | 1.928 | |
| metab_10831 | Somniferine | Morphinans | 0.016 | 0.099 | 0.783 | 0.938 | 1.737 | 1.811 |
| metab_14383 | Precarthamin | Flavonoids | 0.883 | 0.617 | 0.321 | 2.241 | 1.728 | 1.533 |
| metab_10533 | Fatty acyls | 1.483 | 1.328 | 2.196 | 2.850 | 2.975 | 2.861 | |
| metab_7463 | 1,2-anhydridoniveusin | Fatty acyls | 2.032 | 2.039 | 2.266 | 2.809 | 2.787 | 2.866 |
| metab_14094 | Ascladiol | Dihydrofurans | 0.274 | 0.268 | 0.514 | 1.925 | 1.130 | 1.863 |
| metab_8298 | 5′-((Z)-feruloyl) 3-(2′-methylarabinosylxylose) | Cinnamic acids and derivatives | 2.536 | 2.923 | 2.758 | 4.121 | 3.427 | 3.721 |
| metab_11122 | Ac-Ser-Asp-Lys-Pro-OH | Carboxylic acids and derivatives | 2.428 | 2.225 | 2.177 | 2.982 | 3.154 | 2.944 |
| metab_14191 | Endomorphin-1 | Carboxylic acids and derivatives | 1.159 | 1.100 | 1.509 | 2.570 | 2.625 | 2.317 |
| metab_14210 | Gliadorphin | Carboxylic acids and derivatives | 0.040 | 0.181 | 0.009 | 1.511 | 2.148 | 2.076 |
| metab_14282 | Rigin | Carboxylic acids and derivatives | 1.906 | 1.566 | 0.814 | 2.790 | 2.849 | 2.613 |
| metab_14635 | Canavaninosuccinate | Carboxylic acids and derivatives | 1.223 | 0.882 | 1.403 | 2.098 | 2.524 | 2.363 |
| metab_15201 | Folic acid | Carboxylic acids and derivatives | 0.784 | 0.382 | 0.160 | 2.494 | 2.354 | 1.843 |
| metab_8130 | Carboxylic acids and derivatives | 0.410 | 0.252 | 0.286 | 2.290 | 2.333 | 2.210 | |
| metab_14816 | Carboxylic acids and derivatives | 0.405 | 0.507 | 0.618 | 1.823 | 1.517 | 1.695 | |
| metab_10278 | D-vacciniin | Benzene and substituted derivatives | 1.805 | 2.105 | 1.985 | 2.733 | 2.820 | 2.785 |
| metab_15419 | Meta- | Benzene and substituted derivatives | 0.994 | 1.569 | 1.077 | 2.745 | 2.335 | 2.565 |
| metab_15390 | Methyl 6- | Benzene and substituted derivatives | 1.064 | 1.459 | 1.252 | 2.485 | 2.033 | 2.538 |
| metab_10554 | 2-hydroxy-desipramine glucuronide | Benzazepines | 2.018 | 1.860 | 1.934 | 2.676 | 2.801 | 2.653 |
| metab_1609 | Nuatigenin | – | 2.531 | 2.149 | 2.153 | 4.472 | 4.243 | 4.297 |
| metab_3052 | 2-formyloxymethylclavam | – | 0.839 | 1.178 | 0.835 | 1.699 | 1.921 | 1.761 |
| metab_7055 | Homostypolhydroperoxide | – | 1.087 | 1.265 | 0.686 | 2.219 | 1.807 | 1.902 |
| metab_15545 | UDP- | – | 1.823 | 2.074 | 1.352 | 3.187 | 3.233 | 2.943 |
| metab_6502 | (20R,22R)-20,22-dihydroxycholesterol | – | 0.823 | 0.924 | 0.141 | 2.568 | 2.245 | 2.307 |
FIGURE 5Metabolites expression patterns between the compatible and incompatible interaction at 96 hpi. (A) Metabolites with altered abundances [irrespective of the p-value and variable importance in projection (VIP) value] at 96 hpi were divided into ten subclusters according to the expression patterns; each column represents a sample, each row represents a metabolite, and the color indicates the relative abundance of metabolites. (B) Number of metabolites for each subcluster.
FIGURE 6Expression patterns of (A) phenylpropanoids biosynthesis- and (B) terpenoids-related metabolites. Each row represents a metabolite, while each column represents metabolite comparisons. For example, the S3vsS1 column means the log2 (S3/S1). The heatmap was developed via HemI toolkit using log2 fold change (log2FC) values (Deng et al., 2014).